Detection of Hepatitis B virus X-region DNA in liver tissue from patients with Hepatitis C Virus-associated cirrhosis who subsequently developed Hepatocellular Carcinoma

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1153-1156

  Shibata, Yuichi ^a   Nakata, Keisuke ^a   Tsuruta, Shotaro ^a   Hamasaki, Keisuke ^a   Hayashida, Yoshihisa ^a   Kato, Yuji ^a   Nakao, Kazuhiko ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cirrhosis; HBV; HBX; HCV; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033141322     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1153     Document Type: Article

References (27)

1. Beasley RP, Hwang LY, Lin CC and Chien CS: Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133, 1981.
2. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM and Lotze MT: Hepatocellular carcinoma. Ann Intern Med 108: 390-401, 1988.
3. Bosch FX and Munoz N: Hepatocellular carcinoma in the world: eidemiologic questions. In: Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Tabor E, Di Bisceglie AM and Purcell RH (eds). Gulf Publ. Corp., Houston, pp35-54, 1992.
4. Matsuo A, Kusumoto Y, Ohtsuka E, Ohtsuru A, Nakamura Y, Tajima H, Shima M, Nakata K, Muro T, Satoh A, Ishii N, Koji T and Nagataki S: Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan. Lancet 335: 955-957, 1990.
5. Hamasaki K, Nakata K, Tsutsumi T, Tsuruta S, Nakao K, Kato Y, Shima M, Koji T and Nagataki S: Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 40: 146-149, 1993.
6. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H and Kawanishi M: A multivariate anaylsis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47-53, 1993.
7. Edamoto Y, Tani M, Kurata T and Abe K: Hepatitis-C- and -B-virus infections in hepatocellular carcinoma. Cancer 77: 1789-1791, 1996.
8. Sato A, Kato Y, Nakata K, Nakao K, Daikoku M, Ishii N, Matsumoto T, Iseki K, Mazume H and Nagataki S: Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus-and hepatitis C virus-associated cirrhosis. J Gastroenterol Hepatol 11: 944-948, 1996.
9. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, Tanioka H, Yano M and Nagataki S: Risk of hepatocellular carinoma in patients with cirrhosis in Japan: analysis of infectious hepatitis viruses. Cancer 74: 2234-2238, 1994.
10. Tanaka K, Ikematsu H, Hirohata T and Kashiwagi S: Hepatitis-C-virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type-1b (II) infection. J Natl Cancer Inst 88: 742-746, 1996.
11. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, Dc Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V and Diosuardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325: 675-680, 1991.
12. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Graxí A, Ciccaglione A, Giuseppetti R, Stroffolini T and Pagliaro L: Hepatitis C-virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: a case-control study. Ann Intern Med 116: 97-102, 1992.
13. Brunetto MR, Olveri F, Koehler M, Zahm F and Bonino F: Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 351: 1535-1539, 1998.
14. Yu MC, Yuan JM, Ross RK and Govindarajan S: Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 25: 226-228, 1997.
15. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P and Brechot C: Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 17: 20-29, 1993.
16. Kamito H, Nakata K, Hamasaki K, Daikoku M, Mawatari F, Ueki T, Hayashida Y, Nakao K, Kato Y and Nagataki S: Detection of hepatitis virus genome in hepatocellular carcinoma from both hepatitis B surface antigen -and antibody to hepatitis C virus-negative patients: a study using polymerase chain reaction. Oncol Rep 3: 619-623, 1996.
17. Kim CM, Koike K, Saito I, Miyamura T and Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320, 1991.
18. Paterlini P, Poussin K, Kew MC, Franco D and Brechot C: Selective accumulation of the X transcript of hepatitis-B virus in patients negative for hepatitis-B surface antigen with hepatocellular carcinoma. Hepatoloay 21: 313-321, 1995.
19. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JHJ and Harris CC: Abrogation of p53-induced apoptosis by the hepatitis B-virus x gene. Cancer Res 55: 6012-6016, 1995.
20. Nakao T, Enomoto N, Takada N, Takada A and Date T: Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 72: 2105-2112, 1991.
21. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F and Sato C: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81, 1996.
22. Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koide Y, Asano T, Kondo Y, Koike K and Isono K: Identification of hepatitis-B-virus integration in hepatitis-C-virus-infected hepatocellular carcinoma tissues. J Hepatol 26: 771-778, 1997.
23. Gale MJ Jr, Korth MJ, Tang NM, Tang SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR and Katze MG: Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230: 217-227, 1997.
24. Donato F, Boffeta P and Puoti M: A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75: 347-354, 1998.
25. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG and Hoofnagle JH: Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18: 1313-1318, 1993.
26. Rehermann BC, Ferrari C, Pasquinelli C and Chisari FV: The hepatitis B virus persists for decades after recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response. Nat Med 2: 1104-1108, 1996.
27. Chisari FV: Cytotoxic T cells and viral hepatitis. J Clin Invest 99: 1472-1477, 1997.